1. Home
  2. HCKT vs IMRX Comparison

HCKT vs IMRX Comparison

Compare HCKT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hackett Group Inc (The).

HCKT

Hackett Group Inc (The).

HOLD

Current Price

$11.07

Market Cap

324.6M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.19

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCKT
IMRX
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.6M
340.7M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
HCKT
IMRX
Price
$11.07
$4.19
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$17.20
AVG Volume (30 Days)
324.4K
2.3M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
37.75
EPS
0.17
N/A
Revenue
$285,862,000.00
N/A
Revenue This Year
$2.55
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
$63.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.16
$1.67
52 Week High
$25.97
$10.08

Technical Indicators

Market Signals
Indicator
HCKT
IMRX
Relative Strength Index (RSI) 48.66 40.23
Support Level $9.16 N/A
Resistance Level $12.20 $5.47
Average True Range (ATR) 0.49 0.45
MACD 0.07 -0.07
Stochastic Oscillator 34.30 15.27

Price Performance

Historical Comparison
HCKT
IMRX

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: